Vaxcyte, Inc. (PCVX)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
PCVX price, last 12 months
Key stats
- Previous close
- $58.52
- Open
- $58.89
- Day range
- $58.23 – $61.70
- 52-week range
- $42.40 – $90.75
- Volume
- 982.1K
- Avg volume (20 days)
- 1.6M
- Market cap
- $10.0B
Performance
Technicals and fundamentals
About Vaxcyte, Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $10.0B